SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-025880
Filing Date
2024-08-09
Accepted
2024-08-09 16:16:51
Documents
54
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atxi20240630_10q.htm   iXBRL 10-Q 1268613
2 EXHIBIT 31.1 ex_677266.htm EX-31.1 12832
3 EXHIBIT 31.2 ex_677267.htm EX-31.2 12809
4 EXHIBIT 32.1 ex_677268.htm EX-32.1 4900
5 EXHIBIT 32.2 ex_677269.htm EX-32.2 4868
  Complete submission text file 0001437749-24-025880.txt   5689512

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atxi-20240630.xsd EX-101.SCH 52037
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20240630_cal.xml EX-101.CAL 24330
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20240630_def.xml EX-101.DEF 334867
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20240630_lab.xml EX-101.LAB 310027
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20240630_pre.xml EX-101.PRE 359251
57 EXTRACTED XBRL INSTANCE DOCUMENT atxi20240630_10q_htm.xml XML 873608
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 241193040
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)